Evaluation of HRT in peri-and postmenopausal women using the Menopause rating scale (MRS I);Evaluation der hormonersatztherapie in der perimenopause mit dem Menopause rating scale (MRS I)

Zentralblatt fur Gynakologie

Volumn 121, Issue 11, 1999, Pages 530-536

  Hauser, G A ^a   Ernst, U ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; CLIMACTERIUM; CLINICAL ARTICLE; FEMALE; HORMONE SUBSTITUTION; HUMAN; MENOPAUSE; PATIENT CODING; PREMENOPAUSE; RATING SCALE; SYMPTOMATOLOGY;

ADULT; CLIMACTERIC; DRUG ADMINISTRATION SCHEDULE; ESTRADIOL; ESTROGEN REPLACEMENT THERAPY; ESTROGENS; FEMALE; HUMANS; MEDROXYPROGESTERONE 17-ACETATE; MENOPAUSE; MIDDLE AGED; PROGESTERONE CONGENERS; TREATMENT OUTCOME;

EID: 0032701848     PISSN: 00444197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Bruhat MA: Intérêt d'une nouvelle association estroprogestative par voie orale dans le traitement substitutif de la menopause. Abstract Gyneco Bimensuel 109 (1993) 29-32
2. Byrjalsen I, Thorman L, Meinecke B, Riis BJ, Christiansen C: Sequential estrogen and progestogen therapy assessment of progestational effects on the postmenopausal endometrium. Obstet Gynecol 79 (1992) 523-528
3. Egarter Ch, Geurts TBP, Boschitsch E, Speiser P, Huber J: The effects of estradiol plus medroxyprogesterone acetate and conjugated estrogens plus medrogestone on climacteric symptoms and metabolic variables in perimenopausal women. Acta Obstet Gynecol Scand 75 (1996) 386-393
4. Ernst U: Erfahrungen mit einem Sequenzpräparat zur Substitution bei klimakterischen Beschwerden. Gyne 11 (1996) 367-370
5. Gibbons WE, Moyer DL, Lobo RA et al.: Biochemical and histologic effects of sequential estrogen/progestin therapy on the endometrium of postmenopausal women. Am J Obstet Gynecol 154 (1986) 456-461
6. Grodstein F, Stampfer MJ, Goldhaber SZ, Mansen JE, Colditz GA, Speizer FE, Willet WC, Hennekens CH: Prospective study of exogenous hormones and risk pulmonary embolism in women. Lancet 348 (1996) 983-997
7. Haarbo J, Hassager C, Jensen SB, Riis BJ, Christiansen C: Serum Lipids, Lipoproteins and Apolipoproteins during postmenopausal estrogen replacement therapy combined with either 19-nortestosterone derivatives or 17-hydroxy-progesterone derivates. Am J Med 90 (1991) 584-589
8. Haarbo J, Christiansen C: Treatment-induced cyclic variations in serum lipids, lipoproteins and apolipoproteins after 2 years of combined hormone replacement therapy: exaggerated cyclic variations in smokers. Obstet Gynecol 80 (1992) 6393-644
9. Hassager C, Colwell A, Assiri AMA, Eastell R, Russell RGG, Christiansen C: Effect of menopause and hormone replacement therapy on urinary excretion of pyridinium cross-links: a longitudinal and cross-sectional study. Clin Endocrinol 37 (1992) 45-50
10. Hassager C, Fabbri-Mabelli G, Christiansen C: The effect of the menopause and hormone replacement therapy on serum carboxyterminal propeptide of type I collagen. Osteoporosis Int 3 (1993) 50-52
11. Hauser GA, Huber JC, Keller PJ, Lauritzen C, Schneider HPG: Evaluation klimakterischer Beschwerden [Menopause rating scale I (MRS I)]. Zentralbl Gynakol 116 (1994) 16-23
12. Hauser GA: Das larvierte klimakterische Syndrom. J Menopause 1 (1997) 5-12
13. Hauser GA: Häufigkeit der einzelnen klimakterischen Symptome und ihre unterschiedliche Ansprechbarkeit auf Hormonersatztherapie. J Menopause (1999) im Druck.
14. Hirvonen E, Lipasti A, Mälkönen M, Kärkkäinen J, Nuntila J, Timonen H, Manninen V: Clinical and lipid metabolic effects of unopposed oestrogen and two oestrogen progesteron regimens in post-menopausal women. Maturitas 9 (1987) 69-79
15. Jaszmann L: Epidemiology of climacteric and post-climacteric complaints. In: Ageing and Estrogens. Front Hormone Res. Eds.: van Keep PA, Lauritzen C. Bäle: Karger 1973, 22-34
16. Keller PJ: Compliance of oral and transdermal oestrogen replacement therapy. Proc Int Novo-Nordisc Symposium. Copenhague, Denmark 1991, 63-67
17. Kupperman HS, Blatt MHG, Wiesbaden H et al.: Comparative clinical evaluation of estrogen preparations by the menopausal and amenorrhoeal indices. J Clin Endocrinol 13 (1953) 88
18. Marslew U, Riis BJ, Christiansen C: Progestogens: therapeutic and adverse effects in early post-menopausal women. Maturitas 13 (1991) 7-16
19. Marslew U, Riis BJ, Christiansen C: Desogestrel in hormone replacement therapy: long term effects on bone, calcium and lipid metabolism, climacteric symptoms and bleeding. Eur J Clin Invest 21 (1991) 601-607
20. Rosenquist C, Bonde M, Fledelius C, Ovist P: A simple enzyme-linked immunosorbent assay of human osteocalcin. Clin Chem 40 (1994) 1258-1264
21. Schlemmer A, Hassager C, Delmas PD, Christiansen C: Urinary excretion of pyridinium cross-links in healthy women; the long-term effects of menopause and oestrogen/progesteron therapy. Clin Endocrinol 40 (1994) 777-782
22. Silfverstolpe G, Sporröng T, Vilbergsson G, Mattsson LA, Crona N: Comparison the effects of two oestrogen-progestogen combinations on lipid and lipoprotein metabolism (abstract). In: 6th International Congress on the Menopause. Bangkok 1990. Carnforth: Parthenon 1990, 279
23. Sporrong T, Rybo G, Mättson LA, Vilbergson G, Crona N: An objective and subjective assessment of uterine blood loss in postmenopausal women on hormone replacement therapy. Br J Obstet Gynaecol 99 (1992) 399-401
24. Utian WH: Definitive Symptome der Postmenopause -unter Verwendung des vaginalen Parabasalzellindexes. In: Oestrogene in der Postmenopause. Möglichkeiten der Endokrinologie. Bäle: Karger 1975, 79-100
25. van Keep PA, Kellerhals JM: The ageing woman. In: Ageing and Estrogens. Front Hormone Res. Eds.: van Keep PA, Lauritzen C. Bäle: Karger 1973, 160-173